Page 2 - ப்ரிமியர் சுகாதாரம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ரிமியர் சுகாதாரம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ரிமியர் சுகாதாரம் Today - Breaking & Trending Today

COVID-19 Scan for May 11, 2021

COVID-19 death rates low in pregnant, hospitalized women, study finds
Compared with non-pregnant women hospitalized with COVID-19, pregnant women with COVID-19 had lower in-hospital death rates, according to a research letter in the
Annals of Internal Medicine today.
University of Texas (UTHealth) and University of Maryland researchers looked at 1,062 pregnant and 9,815 non-pregnant patients hospitalized with COVID-19 and viral pneumonia from April to November 2020. All were 15 to 45 years old.
Pregnant women had a 0.8% mortality rate, compared with 3.5% in the non-pregnant group, and this difference was seen across sensitivity analyses looking only at intensive care unit patients (3.5% vs 14.9%) and those needing mechanical ventilation (8.6% vs 31.4%). The median time from admission to death was 18 days in pregnant women and 12 days in non-pregnant women. ....

United Kingdom , United States , Astrazeneca Oxford , Beth Pineles , University Of Maryland , University Of Colorado Boulder , Proceedings Of The National Academy Science , United Kingdom Office Of National Statistics Infections , University Of Texas Uthealth , Internal Medicine , Premier Healthcare , National Academy , Colorado Boulder , Natl Acad , United Kingdom Office , National Statistics Infections Survey , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , பல்கலைக்கழகம் ஆஃப் மேரிலாந்து , பல்கலைக்கழகம் ஆஃப் கொலராடோ கற்பாறை , உள் மருந்து , ப்ரிமியர் சுகாதாரம் , தேசிய கலைக்கழகம் , கொலராடோ கற்பாறை , ஒன்றுபட்டது கிஂக்டம் அலுவலகம் ,

Patient ID Now coalition releases national strategic framework for identity, matching

(Photo by bymuratdeniz/Getty Images)
Patient ID Now, a coalition of more than 40 healthcare organizations, released a framework this week aimed at creating a national strategy around patient identification that protects individual safety and security.
In the framework, the coalition calls on the federal government to closely collaborate with the private sector and with other public health authorities in working toward the goal of accurate patient identification.
Throughout the past year, the COVID-19 pandemic has highlighted the urgent need to address the issue of patient identification. The inability to accurately match patients with their records has severe patient safety and financial implications, and impedes health information exchange, said Hal Wolf, president and CEO of ....

United States , Tom Leary , Hal Wolf , Kat Jercich , Blair Childs , Wylecia Wiggs Harris , Ryan Smith , American Health Information Management Association , National Strategy On Patient Identity , American College Of Surgeons , College Of Healthcare Information Management Executives , Office Of The National Coordinator For Health , Healthcare Alliance , American College , Healthcare Information Management Executives , Intermountain Healthcare , Premier Healthcare , Wiggs Harris , National Strategy , Patient Identity , Intermountain Chief Information Officer Ryan , Government Relations Tom Leary , National Coordinator , ஒன்றுபட்டது மாநிலங்களில் , டோம் லீரி , ஹால் ஓநாய் ,

Mount Sinai study finds that blood clotting drug commonly used for orthopedic surgeries does not increase complications for high-risk patients

Journal:
Anesthesiology
Authors: Jashvant Poeran MD, PhD, Director of the Center for Clinical and Outcomes Research, and Associate Professor of Population Health Science & Policy and Orthopedics at the Icahn School of Medicine at Mount Sinai; Calin S. Moucha, MD, Chief of Adult Reconstruction & Joint Replacement Surgery at Mount Sinai Hospital, and Associate Professor of Orthopedics at the Icahn School of Medicine at Mount Sinai; and other coauthors.
Bottom Line: The use of the drug tranexamic acid is commonplace in patients undergoing hip or knee replacement surgery to reduce blood loss. However, this drug works by promoting clotting and safety concerns exist when used in certain high-risk patients such as those with a history of heart attacks, seizures, blood clots, strokes/mini strokes, renal disease, or irregular and rapid heart rates. ....

Calins Moucha , Jashvant Poeran , Why The Research Is Interesting , Professor Of Population Health Science , Icahn School Of Medicine At Mount Sinai , World Health Organization Essential Medicines , Outcomes Research , Mount Sinai Press Office , Paper Title , Tranexamic Acid , Knee Arthroplasty , Associate Professor , Population Health Science , Icahn School , Mount Sinai , Adult Reconstruction , Joint Replacement Surgery , Mount Sinai Hospital , Research Is Interesting , Premier Healthcare , World Health Organization , Essential Medicines , ஏன் தி ஆராய்ச்சி இருக்கிறது சுவாரஸ்யமானது , ப்ரொஃபெஸர் ஆஃப் பாப்யுலேஶந் ஆரோக்கியம் அறிவியல் , இக்ஹ்ன் பள்ளி ஆஃப் மருந்து இல் ஏற்ற சினை , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் அவசியம் மருந்துகள் ,

Honoring The 2021 DEI Champions at The National Diversity &

CONTENT: Press Release
HOUSTON, April 21, 2021 /3BL Media/ - DiversityFirstTM will be hosting the 17th Annual National Diversity and Leadership Conference on April 21-22 and April 28-29, 2021. The conference will be held virtually with this year’s theme being “Be a Changemaker”. The four-day conference will honor a number of diverse talent from different industries.
The DEI Champions Award honors professionals who are passionate about creating an impact in the field of diversity and inclusion. Diversity champions continue to put DiversityFIRST™ through visionary leadership and commitment to fostering change for ages to come. The award commends exemplary professionals who transform our diverse communities into inclusive environments, where individuals are valued for their talent and have the opportunity to reach their full potential. ....

United States , Cleveland Clinic , West Point , New Jersey , Baylor College Of Medicine , Latricia Shepard , Monica Parker , Michelle Gadsen Williams , Anand Kumar , Tricia Anastasio , Lauren Woodfork , Ron Toran , Indria Hollingsworth , Bill Brown , Christopher Johnson , Tiana Carter , James Taylor , Erika White , Jackie Hunter , Krys Tabujara , Ellonda Williams , Andrea Dempsey , Lori Ferguson , Daisy Chan , Matthew Fawcett , Rhonda Burns ,

SARS-CoV-2 Vaccines | Vaccination | JAMA

Shortly after SARS-CoV emerged at the turn of the 21st century, the spike (S) protein (particularly in its prefusion [native] conformation) was identified as the immunodominant antigen of the virus.
1 Evaluation of patients with SARS-CoV-2 revealed that binding and neutralizing antibodies primarily target the receptor-binding domain of the S1 subunit.
2 Once this putative vaccine target was identified, the next challenge was how to best generate an effective immune response to SARS-CoV-2. The characteristics of this response would include production of neutralizing antibodies, generation of a T-cell response, and avoidance of immune-enhanced disease (vaccine-induced response that led to paradoxically increased disease severity on viral challenge). ....

United Kingdom , Vanderbilt University School Of Medicine , Drug Administration , Division Of Infectious Diseases , Protein Subunit , Are Available , Emergency Use Authorization , Infectious Diseases , Vanderbilt University School , Interest Disclosures , Premier Healthcare , Karius Diagnostics , Vir Biotechnology , ஒன்றுபட்டது கிஂக்டம் , வாண்டர்பில்ட் பல்கலைக்கழகம் பள்ளி ஆஃப் மருந்து , பிரிவு ஆஃப் தொற்று நோய்கள் , உள்ளன கிடைக்கிறது , அவசரம் பயன்பாடு அங்கீகாரம் , தொற்று நோய்கள் , வாண்டர்பில்ட் பல்கலைக்கழகம் பள்ளி , ப்ரிமியர் சுகாதாரம் , வீர் உயிரி தொழில்நுட்பவியல் ,